HC Deb 24 October 2000 vol 355 c121W
31. >Mr. Robertson

To ask the Secretary of State for Health, if he will make a statement on the prescribing of beta interferon in Gloucestershire. [131883]

Mr. Denham

In Gloucestershire Health Authority beta interferon is prescribed to patients with relapsing/ remitting multiple sclerosis who fulfil the clinical criteria of the guidelines of the Association of British Neurologists. The health authority has provided additional funding of £300,000 a year to meet the costs of this treatment. This policy will be reviewed following the publication of guidance by the National Institute of Clinical Excellence.